Tim-3 cell signaling and iNOS are involved in the protective effects of ischemic postconditioning against focal ischemia in rats

Metabolic Brain Disease

Volumn 30, Issue 2, 2015, Pages 483-490

  Wei, Dingtai ^a,b   Xiong, Xiaoxing ^a   Zhao, Heng ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

iNOS; Ischemic postconditioning; Stroke; Tim 3

Indexed keywords

3-NITROTYROSINE; ANTIINFLAMMATORY AGENT; CELL SURFACE RECEPTOR; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; MINOCYCLINE; TIM-3 PROTEIN, RAT; TYROSINE;

ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BRAIN ISCHEMIA; DRUG EFFECTS; GENETICS; ISCHEMIC POSTCONDITIONING; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN ISCHEMIA; CYCLOOXYGENASE 2; ISCHEMIC POSTCONDITIONING; MALE; MINOCYCLINE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TYROSINE;

EID: 84938980793     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-014-9543-2     Document Type: Article

References (35)

1. Abas F et al (2010) Neuroprotective effects of postconditioning on lipid peroxidation and apoptosis after focal cerebral ischemia/reperfusion injury in rats. Turk Neurosurg 20:1–8
2. Anderson AC, Anderson DE (2006) TIM-3 in autoimmunity. Curr Opin Immunol 18:665–669
3. Anderson AC et al (2007) Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318:1141–1143
4. Feng R et al (2011) Toll-like receptor 4 is involved in ischemic tolerance of postconditioning in hippocampus of tree shrews to thrombotic cerebral ischemia. Brain Res 1384:118–127
5. Fox C et al (2005) Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 25:1138–1149
6. Gao X et al (2008a) Protective effects of ischemic postconditioning compared with gradual reperfusion or preconditioning. J Neurosci Res 86:2505–2511
7. Gao X et al (2008b) The Akt signaling pathway contributes to postconditioning’s protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem 105:943–955
8. Gielen AW et al (2005) Expression of T cell immunoglobulin- and mucin-domain-containing molecules-1 and −3 (TIM-1 and −3) in the rat nervous and immune systems. J Neuroimmunol 164:93–104
9. Han HS et al (2002) Influence of mild hypothermia on inducible nitric oxide synthase expression and reactive nitrogen production in experimental stroke and inflammation. J Neurosci 22:3921–3928
10. Hirabayashi H et al (2000) Nitrotyrosine generation via inducible nitric oxide synthase in vascular wall in focal ischemia-reperfusion. Brain Res 852:319–325
11. Joo SP et al (2013) Ischemic postconditioning protects against focal cerebral ischemia by inhibiting brain inflammation while attenuating peripheral lymphopenia in mice. Neuroscience 243:149–157
12. Karabiyikoglu M et al (2003) Attenuation of nitric oxide synthase isoform expression by mild hypothermia after focal cerebral ischemia: variations depending on timing of cooling. J Neurosurg 98:1271–1276
13. Koistinaho M et al (2005) Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice. J Cereb Blood Flow Metab 25:460–467
14. Limbourg FP et al (2002) Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest 110:1729–1738
15. Liu XR et al (2012) Ischemic postconditioning diminishes matrix metalloproteinase 9 expression and attenuates loss of the extracellular matrix proteins in rats following middle cerebral artery occlusion and reperfusion. CNS Neurosci Ther 18:855–863
16. Martinez-Murillo R et al (2007) The nitric oxide donor LA 419 decreases brain damage in a focal ischemia model. Neurosci Lett 415:149–153
17. Nakae S et al (2007) TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells. Blood 110:2565–2568
18. Nanetti L et al (2007) Reactive oxygen species plasmatic levels in ischemic stroke. Mol Cell Biochem 303:19–25
19. Pignataro G et al (2008) In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning. J Cereb Blood Flow Metab 28:232–241
20. Ren C et al (2008) Delayed postconditioning protects against focal ischemic brain injury in rats. PLoS One 3:e3851
21. Sanchez-Fueyo A et al (2003) Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 4:1093–1101
22. Su EW et al (2008) TIM-1 and TIM-3 proteins in immune regulation. Cytokine 44:9–13
23. Tang M et al (2010) Minocycline reduces neuronal death and attenuates microglial response after pediatric asphyxial cardiac arrest. J Cereb Blood Flow Metab 30:119–129
24. Wei D et al (2012) The chronic protective effects of limb remote preconditioning and the underlying mechanisms involved in inflammatory factors in rat stroke. PLoS One 7:e30892
25. Xie R et al (2013) Ischemic post-conditioning facilitates brain recovery after stroke by promoting Akt/mTOR activity in nude rats. J Neurochem 127:723–732
26. Xing B et al (2008a) Ischemic post-conditioning protects brain and reduces inflammation in a rat model of focal cerebral ischemia/reperfusion. J Neurochem 105:1737–1745
27. Xing B et al (2008b) Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat. Stroke 39:2362–2369
28. Yin W et al (2007) Preconditioning suppresses inflammation in neonatal hypoxic ischemia via Akt activation. Stroke 38:1017–1024
29. Zawadzka M et al (2012) Early steps of microglial activation are directly affected by neuroprotectant FK506 in both in vitro inflammation and in rat model of stroke. J Mol Med 90:1459–1471
30. Zhao H (2009) Ischemic postconditioning as a novel avenue to protect against brain injury after stroke. J Cereb Blood Flow Metab 29:873–885
31. Zhao H (2011) The protective effects of ischemic postconditioning against stroke: from rapid to delayed and remote postconditioning. Open Drug Discov J 5:138–147
32. Zhao H et al (2005) Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 25:9794–9806
33. Zhao H et al (2006) Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab 26:1114–1121
34. Zhao D et al (2011) Increased T cell immunoglobulin and mucin domain 3 positively correlate with systemic IL-17 and TNF-alpha level in the acute phase of ischemic stroke. J Clin Immunol 31:719–727
35. Zhao H et al (2012) From rapid to delayed and remote postconditioning: the evolving concept of ischemic postconditioning in brain ischemia. Curr Drug Targets 13:173–187